Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,500.00
(
0.43%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
108.54
(
1.37%
)
Bitcoin
68,758.00
(
-0.15%
)
News Focus
News Focus
Post# of 516885
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27712
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: attilathehunt post# 119983

Wednesday, 09/13/2017 9:27:15 AM

Wednesday, September 13, 2017 9:27:15 AM

Post# of 516885
It may also be important to Anavex that with the new FDA rules patient and caregiver testimony could carry more weight than before raising prospects of approval without fully supportive data. A la what happened recently with the approval of Sarepta's Eteplersin for DMD.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News